Lakefront Biotherapeutics (LKFT) Change in Cash (2016 - 2026)
Lakefront Biotherapeutics (LKFT) posted quarterly Change in Cash of -$25.5 million for Q1 2026, down 153.68% year-over-year from $47.5 million in Q1 2025, and down 188.41% quarter-over-quarter from $28.8 million in Q4 2025.
Lakefront Biotherapeutics (LKFT) Change in Cash (2016 - 2026) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has reported Change in Cash for 11 consecutive years, with -$25.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash fell 153.68% year-over-year to -$25.5 million; the TTM figure through Mar 2026 stood at -$44.2 million (down 223.43% YoY), while the FY2025 annual figure was $32.7 million, up 129.32% from the prior year.
- Change in Cash retreated to -$25.5 million in Q1 2026 per LKFT's latest filing, from $28.8 million in the prior quarter.
- Across five years, Change in Cash topped out at $47.5 million in Q1 2025 and bottomed at -$1.1 billion in Q1 2022.
- Historically, Change in Cash has averaged -$138.3 million across 5 years, with a median of -$17.9 million in 2024.
- On a YoY basis, Change in Cash climbed as much as 265.08% in 2025 and fell as far as 2356.01% in 2025.
- Lakefront Biotherapeutics' Change in Cash stood at -$167.0 million in 2022, then soared by 105.38% to $9.0 million in 2023, then fell by 12.15% to $7.9 million in 2024, then soared by 265.08% to $28.8 million in 2025, then tumbled by 188.41% to -$25.5 million in 2026.
- Business Quant data shows LKFT's Change in Cash at -$25.5 million in Q1 2026, $28.8 million in Q4 2025, and -$8.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Lakefront Biotherapeutics | 1.81 Bn | -1.68 Bn | 1.97 Mn | -25.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.48 Mn |
| Dec 31, 2025 | 28.82 Mn |
| Sep 30, 2025 | -8.33 Mn |
| Jun 30, 2025 | -39.25 Mn |
| Mar 31, 2025 | 47.47 Mn |
| Dec 31, 2024 | 7.89 Mn |
| Sep 30, 2024 | -17.92 Mn |
| Jun 30, 2024 | -1.60 Mn |
| Mar 31, 2024 | -102.05 Mn |
| Dec 31, 2023 | 8.99 Mn |
| Mar 31, 2023 | -411.87 Mn |
| Dec 31, 2022 | -166.98 Mn |
| Mar 31, 2022 | -1.12 Bn |
| Jun 30, 2021 | 118.40 Mn |
| Mar 31, 2021 | 457.32 Mn |
| Jun 30, 2020 | -376.12 Mn |
| Mar 31, 2020 | 954.57 Mn |
| Dec 31, 2019 | -3.87 Bn |
| Sep 30, 2019 | 4.92 Bn |
| Jun 30, 2019 | -80.76 Mn |